1 year return (CAGR)
1.50%
Editas Medicine Inc Exchange (NASDAQ, USD)
EDIT
2.92
+0.08 (+3.04%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-33.39%
5 year return (CAGR)
-46.92%
10 year return (CAGR)
-16.28%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
416.20M
Price/Sales
8.85
Ent value
366.47M
Price/Book
3.95
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-1.84%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.64 |
| Daily high | 2.73 |
| Daily low | 2.63 |
| Daily Volume | 2.48M |
| All-time high | 90.58 |
| 1y analyst estimate | 6.00 |
| Beta | 2.09 |
| EPS (TTM) | -0.62 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| EDIT | S&P500 | |
| Current price drop from All-time high | -96.78% | -0.58% |
| Highest price drop | -98.92% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -63.44% | -10.68% |
| Avg time to new high | 111 days | 12 days |
| Max time to new high | 1428 days | 1805 days |
News
